StonvexLoading…
StonvexStonvexStonvexCore line items from SRTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 |
|---|---|---|---|
Revenue | $27.48M | $41.81M | $24.41M |
Operating Income | $-10.31M | $8.09M | $-382.00K |
Net Income | $-7.72M | $6.65M | $485.00K |
EPS (Diluted) | $-0.47 | $0.41 | $0.03 |
Total Assets | $53.04M | $62.16M | $53.71M |
Total Liabilities | $4.94M | $6.34M | $4.87M |
Cash & Equivalents | $22.08M | $22.06M | $23.15M |
Free Cash Flow OCF − CapEx | $332.00K | $-1.11M | $-2.37M |
Shares Outstanding | 16.46M | 16.50M | 16.37M |